Home › Esophageal Cancer › Florida › Fort Lauderdale
Esophageal Cancer clinical trials in Fort Lauderdale, FL
3 studies for Esophageal Cancer are looking for participants at sites in and around Fort Lauderdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Holy Cross Hospital, Fort Lauderdale
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Holy Cross Hospital, Fort Lauderdale
- Broward Health Medical Center, Fort Lauderdale
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- Holy Cross Hospital (site 213), Fort Lauderdale
About Esophageal Cancer
Early esophageal cancer does not have symptoms. Factors that increase risk include heavy drinking and smoking. Learn how you can reduce your risk.
More about Esophageal Cancer on MedlinePlus
Esophageal Cancer trials in other cities
- Houston, TX36 studies
- Boston, MA23 studies
- New York City, NY22 studies
- Nashville, TN19 studies
- St. Louis, MO17 studies
- Pittsburgh, PA15 studies
- Los Angeles, CA15 studies
- Baldwin Park, CA14 studies
- Grand Rapids, MI14 studies
- Philadelphia, PA13 studies
- San Antonio, TX12 studies
- Rochester, MN11 studies
Other studies in Fort Lauderdale
- Non-Small Cell Lung Cancer12 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Heart Failure6 studies
- Macular Degeneration5 studies
- Ovarian Cancer4 studies
- Breast Cancer4 studies
- Multiple Myeloma3 studies
- Blood Cancers3 studies
- Chronic Kidney Disease3 studies
- Cardiovascular Disease3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.